Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use study
Authors:
Open Access
- 1 December 2000
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 111 (4) , 1122-1129
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Defibrotide as salvage therapy for refractory veno-occlusive disease of the liver complicating allogeneic bone marrow transplantationBone Marrow Transplantation, 1999
- Venoocclusive disease of the liver after marrow transplantation: Histological correlates of clinical signs and symptomsHepatology, 1994
- Defibrotide versus Placebo in the Treatment of Intermittent ClaudicationClinical Drug Investigation, 1994
- Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation.Journal of Clinical Oncology, 1993
- Defibrotide, a single-stranded polydeoxyribonucleotide acting as an adenosine receptor agonistEuropean Journal of Pharmacology, 1993
- Veno-occlusive Disease of the Liver and Multiorgan Failure after Bone Marrow Transplantation: A Cohort Study of 355 PatientsAnnals of Internal Medicine, 1993
- DefibrotideDrugs, 1993
- Liver veno-occlusive disease after bone marrow transplantation changes in coagulation parameters and endothelial markersThrombosis Research, 1991
- VENOOCCLUSIVE DISEASE OF THE LIVER FOLLOWING BONE MARROW TRANSPLANTATIONTransplantation, 1987
- Effect of a New Antithrombotic Agent (Defibrotide) in Acute Renal Failure Due to Thrombotic MicroangiopathyNephron, 1985